Literature DB >> 12864958

Diagnosis and treatment of bacterial diarrhea.

James V Lawler1, Mark R Wallace.   

Abstract

Diarrheal illness caused by bacterial pathogens is a global health problem and remains one of the most common complaints prompting patients to seek medical care. Strategies to increase the yield of stool culture and new rapid diagnostic tests can improve diagnostic ability. Emerging antimicrobial resistance among the common bacterial causes of diarrhea has made treatment more challenging. Emerging fluoroquinolone resistance is a particular concern. Recent studies of rifaximin, a nonabsorbed antibiotic for the treatment of bacterial diarrhea, have shown favorable results. Rifaximin may represent a much-needed addition to the armamentarium against bacterial agents.

Entities:  

Mesh:

Year:  2003        PMID: 12864958     DOI: 10.1007/s11894-003-0065-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  58 in total

Review 1.  Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea.

Authors:  R Steffen
Journal:  J Travel Med       Date:  2001-12       Impact factor: 8.490

2.  Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.

Authors:  L J Goodman; G M Trenholme; R L Kaplan; J Segreti; D Hines; R Petrak; J A Nelson; K W Mayer; W Landau; G W Parkhurst
Journal:  Arch Intern Med       Date:  1990-03

Review 3.  Escherichia coli. EAEC, EHEC, EIEC, ETEC.

Authors:  P H Gilligan
Journal:  Clin Lab Med       Date:  1999-09       Impact factor: 1.935

4.  Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay.

Authors:  S Johnson; S A Kent; K J O'Leary; M M Merrigan; S P Sambol; L R Peterson; D N Gerding
Journal:  Ann Intern Med       Date:  2001-09-18       Impact factor: 25.391

5.  Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area.

Authors:  M Hindiyeh; S Jense; S Hohmann; H Benett; C Edwards; W Aldeen; A Croft; J Daly; S Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.

Authors:  C W Hoge; J M Gambel; A Srijan; C Pitarangsi; P Echeverria
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

7.  Evaluation and diagnosis of acute infectious diarrhea.

Authors:  R L Guerrant; D S Shields; S M Thorson; J B Schorling; D H Gröschel
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

Review 8.  Clostridium difficile infection.

Authors:  D H Gröschel
Journal:  Crit Rev Clin Lab Sci       Date:  1996       Impact factor: 6.250

9.  Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.

Authors:  H E Pichler; G Diridl; K Stickler; D Wolf
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

10.  Ofloxacin-resistant Vibrio cholerae O139 in Hong Kong.

Authors:  K M Kam; K Y Luey; T L Cheung; K Y Ho; K H Mak; P T Saw
Journal:  Emerg Infect Dis       Date:  1999 Jul-Aug       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.